Zhejiang Orient Gene Biotech (688298.SH) Subsidiary Obtains Medical Device Registration Certificates

Stock News
2025/11/04

Zhejiang Orient Gene Biotech Co., Ltd. (688298.SH) announced that its subsidiaries, Shanghai Wanzijian Biotechnology Co., Ltd. and Healgen Scientific LLC (referred to as "Healgen"), have recently obtained medical device registration certificates for multiple products in China, Australia, and Singapore.

The newly certified products expand the company's flow fluorescence technology platform portfolio. Notably, the respiratory triple-test product enhances market accessibility in international markets, facilitating broader domestic and global expansion for related products.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10